Tom Thuren
4Patents
2h-index
7Co-inventors
33Inventor score
Filing activity: Mar 29, 2011 → Apr 10, 2017
Most-cited inventions
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US9061012B2 | Uses of DGAT1 inhibitors | Human Necessities | 3 | Active |
| US9683038B2 | Methods of reducing the risk of experiencing a cardiovascular (CV) event or a cerebrovascular event in a patient that has suffered a qualifying CV event | Chemistry; Metallurgy | 2 | Active |
| US10975145B2 | Methods of reducing the risk of experiencing a cardiovascular (CV) event or a cerebrovascular event in a patient that has suffered a qualifying CV event | Chemistry; Metallurgy | 0 | Active |
| US10000565B2 | Use of IL-1 β binding antibodies for treating peripheral arterial disease | Chemistry; Metallurgy | 0 | Active |
Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.